xadago
zambon spa - safinamide methanesulfonate - parkinson disease - anti-parkinson drugs - xadago is indicated for the treatment of adult patients with idiopathic parkinson’s disease (pd) as add-on therapy to a stable dose of levodopa (l-dopa) alone or in combination with other pd medicinal products in mid-to late-stage fluctuating patients.
otozambon combination solution
pharmalink store italy - 1 glass vial (25 ml) - solution - combination - ear nose , oropharynx-ear
fluimucil acetylcysteine 600 mg effervescent tablets
zambon spa via lillo del duca, 10, 20091 bresso (milan), italy - effervescent tablet - acetylcysteine 600 mg - cough and cold preparations
monuril 3g granules sachets
zambon uk ltd - fosfomycin trometamol - granules for oral solution - 3gram
fluimucil solution for i/v injection and inhalation
zambon s.p.a. - acetylcysteine - solution for i/v injection and inhalation - 100mg/ml
fluimucil tablets effervescent
zambon switzerland ltd. - acetylcysteine - tablets effervescent - 600mg
promixin 1million unit powder for nebuliser solution unit dose vials
zambon uk ltd - colistimethate sodium - powder for nebuliser solution - 1000000unit
monuril 3g granules for oral solution
zambon spa via lillo del duca, 10, 20091 bresso (milan), italy - fosfomycin - granules for oral solution - fosfomycin 3 g - antibacterials for systemic use
promixin 1million unit powder for solution for injection vials
zambon uk ltd - colistimethate sodium - powder for solution for injection - 1000000unit
fluimucil 200 mg granules for oral solution
zambon s.p.a. - acetylcysteine - granules for oral solution - 200 milligram(s) - mucolytics; acetylcysteine - fluimucil is indicated in acute and chronic bronchitis and other respiratory conditions associated with the production of viscous mucus. fluimucil is also indicated for use in patients with abdominal complications associated with cystic fibrosis.